Prescription drug · ANDA
Cyproheptadine Hydrochloride NDC 50090-6129
Cyproheptadine hydrochloride 4 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6129-1 | 5009061290150090612901 | 30 TABLET in 1 BOTTLE (50090-6129-1)Marketed from Oct 3, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cyproheptadine Hydrochloride
- Generic name (nonproprietary)
- cyproheptadine hydrochloride
- Active ingredients
- Cyproheptadine hydrochloride — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208938
- Marketing start
- Listing expires
- Identifiers
- Product ID 50090-6129_65894e51-4a95-421d-96e2-68483b3af453SPL ID 65894e51-4a95-421d-96e2-68483b3af453SPL set ID 0e43e99b-2e0b-4f55-b93a-a6908634880dRxCUI 866144UNII NJ82J0F8QC
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090612901followed by a unit qualifier and the quantityPackage 50090-6129-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Amelioration of allergic reactions to blood or plasma Cold urticaria Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the cute manifestations have been controlled.
Excerpt only. Read the full label for complete information.
About NDC 50090-6129
- What is NDC 50090-6129?
- 50090-6129 is the product NDC for Cyproheptadine Hydrochloride, Cyproheptadine hydrochloride 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cyproheptadine Hydrochloride.
- What is the active ingredient?
- Cyproheptadine hydrochloride.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cyproheptadine Hydrochloride?
- 34 other product NDCs are listed under this name. See all Cyproheptadine Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cyproheptadine Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/1 | TabletOral | PANGEA PHARMACEUTICALS, LLC | 81279-129 | 81279-0129-3081279-0129-60 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | TRUPHARMA, LLC | 52817-415 | 52817-0415-1052817-0415-50 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4667 | 70518-4667-00 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | AvPAK | 50268-201 | 50268-0201-15 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SolutionOral | Atlantic Biologicals Corp. | 17856-1185 | 17856-1185-0117856-1185-02 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SolutionOral | QUAGEN PHARMACEUTICALS LLC | 70752-185 | 70752-0185-12 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3517 | 70518-3517-00 |
| Cyproheptadine Hydrochloride | Cyproheptadine 2 mg/5mL | SolutionOral | Patrin Pharma, Inc. | 39328-544 | 39328-0544-16 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-805 | 16571-0805-0116571-0805-10 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SyrupOral | Tris Pharma Inc | 27808-099 | 27808-0099-01 |
Other NDCs under ANDA 208938
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1110 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1076 |